跳至主要内容
临床试验/NCT05760534
NCT05760534已完成4 期

Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia - a Phase 4 Clinical Trial

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2023年3月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
110
试验地点
1
主要终点
Incidence of intraoperative respiratory depression

研究概览

简要总结

This study aims to compare ideal body weight- and total body weight-based dosage for remimazolam sedation of obese patients undergoing knee or hip arthroplasty under spinal anesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for elective knee or hip arthroplasty under spinal anesthesia
  • American Society of Anesthesiologists (ASA) classification I, II, III

排除标准

  • Patient refusal
  • Contraindication for spinal anesthesia
  • Contraindication for remimazolam infusion
  • History of hypersensitivity to remimazolam
  • History of chronic use of benzodiazepine or opioid
  • Baseline MOAA/S score of 4 or lower
  • Pregnancy

研究组 & 干预措施

Ideal body weight group

Experimental

干预措施: Remimazolam (Drug)

Total body weight group

Active Comparator

干预措施: Remimazolam (Drug)

结局指标

主要结局

Incidence of intraoperative respiratory depression

时间窗: From entrance to exit from the operating room

Incidence of intraoperative respiratory depression

次要结局

  • Incidence of intraoperative oxygen desaturation(From entrance to exit from the operating room)
  • Incidence of intraoperative nausea or vomiting(From entrance to exit from the operating room)
  • Incidence of intraoperative hypotension(From entrance to exit from the operating room)
  • Intraoperative Patient State Index (PSi)(From entrance to exit from the operating room)
  • Length of stay at the post-anesthesia care unit (PACU)(From entrance to exit from the PACU)
  • Incidence of intraoperative tachycardia(From entrance to exit from the operating room)
  • Incidence of postoperative hypotension(From entrance to exit from the PACU)
  • Incidence of postoperative hypertension(From entrance to exit from the PACU)
  • Total remimazolam infusion dose(From start to end of remimazolam infusion)
  • Incidence of intraoperative hypertension(From entrance to exit from the operating room)
  • Incidence of intraoperative bradycardia(From entrance to exit from the operating room)
  • Incidence of intraoperative hiccups(From entrance to exit from the operating room)
  • Incidence of intraoperative paradoxical movements(From entrance to exit from the operating room)
  • Time to reach MOAA/S score 5 after end of surgery(From end of remimazolam infusion until time of full alertness)
  • Patient satisfaction(At exit from PACU)
  • Intraoperative recall(At exit from PACU)
  • Incidence of postoperative nausea or vomiting(From entrance to exit from the PACU)
  • Incidence of postoperative respiratory depression(From entrance to exit from the PACU)
  • Modified Observer's Assessment of Alertness/Sedation (MOAA/S) score(From start of remimazolam infusion until time of full alertness)
  • Incidence of postoperative delirium(From end of surgery to third postoperative day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jin-Tae Kim

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验